With a legacy that spans over four decades, ATRAS JORDAN proudly carries forward the rich history of its predecessor, ALNILEIN Trading Est, originally founded in 1991. Our journey is one of growth, innovation, and impact—built on strong foundations and driven by a passion for excellence.

Over the years, we have successfully established numerous industrial ventures specializing in human and veterinary pharmaceuticals. These enterprises have reached the highest standards of quality and performance and are widely recognized as leaders in their fields.

In 2023, we rebranded as ATRAS JORDAN, marking a new chapter in our story while honoring the legacy of ALNILEIN. This transition reflects our broadened vision as a regional representative and strategic intermediary for global pharmaceutical companies, particularly across the MENA region. We work closely with our international partners to explore and penetrate emerging markets in human and veterinary medicine and related sectors.

At ATRAS JORDAN, we are more than just a trading company—we are a trusted partner in specialized pharmaceutical investments and services. With decades of expertise, we assist our clients and collaborators in launching successful, cost-effective projects using advanced technologies, ensuring both operational efficiency and profitability.

Our Business Development Department plays a crucial role in fostering international collaborations and unlocking opportunities for companies aiming to expand into the medical and pharmaceutical sectors globally. We are committed to building long-term relationships based on trust, integrity, and shared success.

As you explore our platform, we hope it provides valuable insights into the innovative products and services we offer. Should you need any further assistance, please don’t hesitate to reach out.
We’re here to help—just contact us at info@atrasjordan.com.

Thank you for visiting ATRAS JORDAN—where experience meets innovation.